Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?

scientific article published on 20 June 2017

Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S40618-017-0717-8
P698PubMed publication ID28634704

P2093author name stringL Bartalena
E Piantanida
P2860cites workMANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trialsQ28077018
Graves' Disease.Q30243909
Teprotumumab for Thyroid-Associated Ophthalmopathy.Q34556184
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.Q35055076
Randomized controlled trial of rituximab in patients with Graves' orbitopathyQ35055124
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyQ36811289
Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).Q38869637
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathyQ38877933
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?Q38972962
Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' OrbitopathyQ58109526
P433issue8
P304page(s)885-887
P577publication date2017-06-20
P1433published inJournal of Endocrinological InvestigationQ15766847
P1476titleTeprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?
P478volume40

Reverse relations

cites work (P2860)
Q89620715Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
Q97421343Teprotumumab: a disease modifying treatment for graves' orbitopathy
Q50254727Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients

Search more.